A Study to Assess Efficacy and Safety of Oral Tazemetostat in Adult Participants With Relapsed/Refractory Follicular Lymphoma That Does Not Have an "EZH2 Gain-of-function" Genetic Mutation
Clinical trial NCT06068881 · WITHDRAWN
Trial details
- NCT number
- NCT06068881
- Sponsor
- Epizyme, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-02
- Primary completion
- 2029-04-06
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.